title: Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.
authors.affiliation: Department of Pharmacokinetics and Drug Delivery, Groningen University Institute of Drug Exploration, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. k.temming@rug.nl
authors.forename: Kai
authors.initials: K
authors.lastname: Temming
authors.forename: Marie
authors.initials: M
authors.lastname: Lacombe
authors.forename: Roel Q J
authors.initials: RQ
authors.lastname: Schaapveld
authors.forename: László
authors.initials: L
authors.lastname: Orfi
authors.forename: Gyorgy
authors.initials: G
authors.lastname: Kéri
authors.forename: Klaas
authors.initials: K
authors.lastname: Poelstra
authors.forename: Grietje
authors.initials: G
authors.lastname: Molema
authors.forename: Robbert J
authors.initials: RJ
authors.lastname: Kok
mesh_terms: D000418:Albumins / Q000737:chemistry*; D015195:Drug Design; D004730:Endothelium, Vascular / Q000187:drug effects*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D009842:Oligopeptides / Q000737:chemistry*; D010793:Phthalazines / Q000737:chemistry / Q000494:pharmacology*; D011725:Pyridines / Q000737:chemistry / Q000494:pharmacology*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D000418:Albumins; D009842:Oligopeptides; D010793:Phthalazines; D011725:Pyridines; C404768:vatalanib; C047981:arginyl-glycyl-aspartic acid; D040262:Receptors, Vascular Endothelial Growth Factor